Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002

被引:40
作者
Yang, YL
Li, SY
Cheng, HH
Lo, HJ [1 ]
机构
[1] Natl Hlth Res Inst, Div Clin Res, Miaoli County 350, Taiwan
[2] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan
[3] Ctr Dis Control, Div Lab Res & Dev, Lab Mycopathogen Chlamydia & Mycoplasma, Taipei 11561, Taiwan
关键词
Candida; susceptibility; resistance;
D O I
10.1016/j.diagmicrobio.2004.11.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Susceptibilities to amphotericin B and fluconazole of 909 Candida species collected during the Taiwan Surveillance of Antimicrobial Resistance of Yeasts (TSARY) in 2002 were determined by the broth microdilution method. There were 395 (43.5%) Candida albicans, 244 (26.8%) C. tropicalis, 187 (20.6%) C. glabrata, 63 (6.9%) C. parapsilosis, 9 (1%) C. krusei, and 11 (1.2%) others. Among them, 23 (2.5%) isolates were resistant to amphotericin B. They consisted of 10 C. glabrata, 6 C. krusei, 3 C. albicans, 1 C. tropicalis, 1 C. parapsilosis, and 2 others. The resistance rate to amphotericin B has increased compared with that of TSARY 1999 (2.5% versus 0.5%). There were 7 C. krusei, 5 C. albicans, 3 C. glabrata, and 2 others isolates resistant to fluconazole. The resistance rate to fluconazole has decreased from 8.4% in 1999 to 1.9% in 2002. A pattern of coresistance to both amphotericin B and fluconazole was observed. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 21 条
[1]   The epidemiology of hematogenous candidiasis caused by different Candida species [J].
AbiSaid, D ;
Anaissie, E ;
Uzun, O ;
Raad, I ;
Pinzcowski, H ;
Vartivarian, S .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1122-1128
[2]   EMERGENCE OF CANDIDA-KRUSEI INFECTIONS AFTER THERAPY OF OROPHARYNGEAL CANDIDIASIS WITH FLUCONAZOLE [J].
AKOVA, M ;
AKALIN, HE ;
UZUN, O ;
GUR, D .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (07) :598-599
[3]  
BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
[4]  
Chen YC, 1997, INFECT CONT HOSP EP, V18, P369, DOI 10.1086/647628
[5]   In vitro antifungal susceptibilities of Candida species isolated from the blood [J].
Chen, YC ;
Chang, SC ;
Hsieh, WC ;
Luh, KT .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1996, 7 (03) :217-222
[6]  
HADFIELD TL, 1987, REV INFECT DIS, V9, P1006
[7]  
Hung CC, 1996, J FORMOS MED ASSOC, V95, P19
[8]  
LARONE DH, 1995, MED IMPORTANT FUNGI, P209
[9]  
Lo Hsiu-Jung, 2001, Journal of Microbiology Immunology and Infection, V34, P171
[10]   Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans [J].
Marr, KA ;
Lyons, CN ;
Ha, K ;
Rustad, TR ;
White, TC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :52-59